Skip to main content
Synthesis

Prohormone Convertases and Proteolytic Processing

Most bioactive peptides are carved from larger precursor proteins by prohormone convertases, a family of serine proteases that cleave at specific basic residue pairs.

By MVP Peptides Research Team
Reviewed by MVP Peptides Research Team
Published:
Last updated:

Key Points

  • 1 PC1/3 and PC2 are the primary neuroendocrine prohormone convertases
  • 2 Cleavage occurs at paired basic residues (Lys-Arg, Arg-Arg)
  • 3 POMC demonstrates tissue-specific processing into different peptides
  • 4 Carboxypeptidase E trims residual basic amino acids after PC cleavage

The transformation from protein precursor to active peptide is one of biology's most elegant processing systems.

The Prohormone Convertase Family

Prohormone convertases (PCs) are a family of subtilisin-like serine proteases:

PC1/3 (PCSK1) - Primary converter of proinsulin, proglucagon, POMC - Expressed in neuroendocrine cells - Cleaves at **Arg-X-X-Arg↓** and **Lys-Arg↓** sites

PC2 (PCSK2) - Works with PC1/3 for complete processing - Often performs second cleavage - Requires 7B2 chaperone for activation

Furin (PCSK3) - Ubiquitously expressed (constitutive pathway) - Cleaves growth factors, receptors, viral proteins - Minimal motif: **Arg-X-Lys/Arg-Arg↓**

The Processing Pathway

1. Signal Peptide Removal - Occurs co-translationally in the ER - Signal peptidase cleaves ~20 AA leader sequence - **Prepropeptide → Propeptide**

2. Trafficking to Secretory Granules - Propeptide sorted in trans-Golgi network - Aggregation with chromogranins - Budding into immature secretory granules

3. Endoproteolytic Cleavage - Granules acidify as they mature (pH ~5.5) - PCs activate in acidic environment - Cleavage at paired basic residues

4. Carboxypeptidase E Trimming - Removes C-terminal basic residues left by PCs - **Peptide-Lys/Arg → Peptide**

5. Final Modifications - **PAM** — Amidation of C-terminal glycine - **Other PTMs** — Sulfation, acetylation, etc.

Case Study: POMC Processing

Pro-opiomelanocortin (POMC) demonstrates tissue-specific processing:

  • POMC → ACTH + β-lipotropin
  • ACTH → α-MSH + CLIP
  • β-lipotropin → γ-lipotropin + β-endorphin

The same precursor produces different peptides in different tissues!

Clinical Significance

Genetic Disorders - **PC1/3 deficiency** — Obesity, hypoglycemia, intestinal dysfunction - **PC2 deficiency** — Hypoglycemia, processing defects

Therapeutic Targets - **PCSK9 inhibitors** — Lower LDL cholesterol - **Furin inhibitors** — Antiviral (prevent spike protein cleavage)

Why This System Evolved

  1. **Efficiency** — One gene produces multiple peptides
  2. **Control** — Processing only in specialized cells
  3. **Storage** — Inactive precursors can be stockpiled
  4. **Diversity** — Tissue-specific processing patterns
  5. **Regulation** — Processing can be modulated

Test Your Knowledge

Take this quick quiz to reinforce what you've learned about prohormone convertases and proteolytic processing.

Question 1 of 30 correct

At what type of amino acid sequence do prohormone convertases typically cleave?